Recall of Immulite anti-TPO / reference LKT01;Immulite 2000 anti-TG / reference L2KTG2

According to L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), this recall involved a device in France that was produced by DPC France.

What is this?

A correction or removal action taken by a manufacturer to address a problem with a medical device. Recalls occur when a medical device is defective, when it could be a risk to health, or when it is both defective and a risk to health.

Learn more about the data here
  • Type of Event
    Recall
  • Date
    2002-02-01
  • Event Country
  • Event Source
    ANSM
  • Event Source URL
  • Notes / Alerts
    French data is current through early September 2018. All of the data comes from L’Agence nationale de sécurité du médicament et des produits de santé (ANSM), except for the categories Manufacturer Parent Company and Product Classification.
    The Parent Company and the Product Classification were added by ICIJ.
    The parent company information is based on 2017 public records. The device classification information comes from FDA’s Product Classification by Review Panel, based on matches of recall data from the U.S. and France.
  • Extra notes in the data
  • Action
    The company DPC France withdraws from the market batches 175 and 175A (per 31.08.02) of the reagent called Immulite anti-TPO / reference LKT01 and lots 202 (per 30.07.02) and 203 (per 30.07.02) of the reagent called Immulite 2000 anti-TG / reference L2KTG2 following a decline in stability of the adjuster used to calibrate the tests, resulting in a low activity in cps (shots per second) of the adjuster, which may lead to an increase in values ​​obtained for the samples tested.

Device

  • Model / Serial
  • Product Description
    in-vitro_medical_device
  • Manufacturer

Manufacturer

  • Source
    LAANSM